GSE	Species	PMID	Paper	Title	CellType	Tissue	Disease	Cell_Pop	Release_Date	Last_Update_Date	SRA	Cell_Line	GSMs	fields_dataType	Key_Match
GSE221321	Homo sapiens	None	None	Compressed Perturb-seq: highly efficient screens for regulatory circuits using random composite perturbations	None	None	None	None	2023-01-01	2023-01-03	SRX18774274; SRX18774277; SRX18774275; SRX18774276	None	GSM6858450; GSM6858448; GSM6858449; GSM6858447	{'Series/Title': 'Compressed Perturb-seq: highly efficient screens for regulatory circuits using random composite perturbations', 'Series/Summary': 'Pooled CRISPR screens with single-cell RNA-seq readout (Perturb-seq) have emerged as a key technique in functional genomics, but are limited in scale by cost and combinatorial complexity. Here, we reimagine Perturb-seqâ€™s design through the lens of algorithms applied to random, low-dimensional observations. We present compressed Perturb-seq, in which we measure multiple perturbations per cell or multiple cells per droplet, and decompress these measurements by leveraging the sparse structure of regulatory circuits. Applying compressed Perturb-seq to 598 genes in the immune response to bacterial lipopolysaccharide, we achieve the same accuracy as conventional Perturb-seq at 4 to 20-fold reduced cost, with greater power to learn genetic interactions. We identify known and novel regulators of immune responses and uncover evolutionarily constrained genes with downstream targets enriched for immune disease heritability, including many missed by existing GWAS or trans-eQTL studies. Our framework enables new scales of interrogation for a foundational method in functional genomics.', 'Series/Type': 'Expression profiling by high throughput sequencing', 'Series/Overall-Design': 'scRNA-seq of THP-1 cells expressing Cas9 or dCas9-KRAB transduced with sgRNA libraries targeting 598 genes as well as non-targeting controls, using both the conventional Perturb-seq experimental protocol as well as our modifications for compressed Perturb-seq. Cells were treated with LPS for 3 hours before sequencing.', 'Series/Status/Release-Date': '2023-01-01', 'Series/Status/Last-Update-Date': '2023-01-03', 'Sample/Channel/Characteristics': '3 hours LPS      ; 3 hours LPS      ; 3 hours LPS      ; 3 hours LPS      ', 'Sample/Relation': 'SRX18774274; SRX18774277; SRX18774275; SRX18774276'}	{'match_res0': {'Series/Summary0': ['CRISPR']}, 'match_res1': {}, 'match_res2': {'Series/Summary2': ['immune']}}
GSE221250	Homo sapiens	None	None	CRISPR deletion of ELAVL1 (HuR) in MIA PaCa-2 in vitro cells and in vivo tumors	None	None	None	None	2023-01-01	2023-01-04	SRX18761653; SRX18761654; SRX18761655; SRX18761656; SRX18761657; SRX18761658; SRX18761660; SRX18761661; SRX18761662; SRX18761663; SRX18761664; SRX18761665; SRX18761666; SRX18761667; SRX18761668; SRX18761669; SRX18761670; SRX18761671; SRX18761672; SRX18761673; SRX18761674; SRX18761675; SRX18761676; SRX18761677; SRX18761678; SRX18761679	None	GSM6856851; GSM6856853; GSM6856863; GSM6856857; GSM6856867; GSM6856864; GSM6856855; GSM6856850; GSM6856860; GSM6856852; GSM6856866; GSM6856843; GSM6856854; GSM6856861; GSM6856868; GSM6856862; GSM6856856; GSM6856849; GSM6856846; GSM6856845; GSM6856848; GSM6856858; GSM6856847; GSM6856859; GSM6856865; GSM6856842; GSM6856844	{'Series/Title': 'CRISPR deletion of ELAVL1 (HuR) in MIA PaCa-2 in vitro cells and in vivo tumors', 'Series/Summary': 'To investigate the impact of the mRNA stabilty factor HuR on the pancreatic cancer transcriptome in MIA PaCa-2 in vitro cell line and in vivo tumors at multiple time points of tumor growth', 'Series/Type': 'Expression profiling by high throughput sequencing', 'Series/Overall-Design': 'CRISPR-mediated deletion of ELAVL1 (HuR) in MIA PaCa-2 PDAC cells. HuR wildtype (WT) or HuR knockout (KO) cells in culture (in vitro) were collected at 70% confuency for RNA extraction. HuR WT and HuR KO orthotopic tumors (in vivo) were harvested 2, 3, and 4 weeks post-injection for RNA extraction.', 'Series/Status/Release-Date': '2023-01-01', 'Series/Status/Last-Update-Date': '2023-01-04', 'Sample/Channel/Characteristics': '', 'Sample/Relation': 'SRX18761653; SRX18761654; SRX18761655; SRX18761656; SRX18761657; SRX18761658; SRX18761660; SRX18761661; SRX18761662; SRX18761663; SRX18761664; SRX18761665; SRX18761666; SRX18761667; SRX18761668; SRX18761669; SRX18761670; SRX18761671; SRX18761672; SRX18761673; SRX18761674; SRX18761675; SRX18761676; SRX18761677; SRX18761678; SRX18761679'}	{'match_res0': {'Series/Title0': ['CRISPR']}, 'match_res1': {'Series/Summary1': ['cancer']}, 'match_res2': {}}
